Trial
NCT05710185
Deucravacitinib for the Treatment of Palmoplantar Pustulosis
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
University of Pennsylvania
Condition
Palmoplantar Pustulosis
Intervention
Deucravacitinib
Why stopped
Sponsor terminated funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-07